ME 12 Injection contains Methylcobalamin 500 mcg, an active form of vitamin B12 essential for neurological function and hematopoiesis. It is indicated for the treatment of vitamin B12 deficiency, which may present as pernicious anemia, neuropathies, or other conditions associated with impaired vitamin B12 absorption or metabolism. Methylcobalamin plays a critical role in DNA synthesis, red blood cell formation, and maintenance of the myelin sheath surrounding nerves, thereby supporting nerve regeneration and repair. ME 12 Injection is administered intramuscularly or intravenously, allowing rapid correction of deficiency states and symptomatic relief in neuropathic conditions such as diabetic neuropathy, peripheral neuropathy, and certain neurodegenerative disorders. The dosage and duration of therapy depend on the severity of the deficiency and clinical response. Adverse effects are rare but may include mild injection site reactions or hypersensitivity. Caution is advised in patients with known hypersensitivity to cobalamin compounds. ME 12 Injection should be used under medical supervision, with appropriate monitoring of hematological parameters and clinical symptoms. This formulation offers a reliable and effective option for correcting methylcobalamin deficiency and supporting neurological health.